Wound closure market set to grow in Europe:
This article was originally published in Clinica
Executive Summary
The European market for wound closure products is forecast to rise from $814 million in 1999 to $1,172 million by 2006, according to a new report from Frost & Sullivan. European Wound Closure Markets highlights the synthetic absorbable suture and tissue sealant segments as offering the best prospects, with the latter recording market growth of 17.3% in 1999. The tissue sealant market is characterised by a lack of customer loyalty and low levels of customer satisfaction, the report says. For further details: www.frost.com
You may also be interested in...
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.
Colorado Price Cap Plan For Enbrel Draws Amgen Lawsuit; Cosentyx, Stelara ‘Affordability’ Reviews Pending
However, the state's recently formed prescription drug affordability board found Gilead’s Genvoya and Vertex’s Trikafta to be affordable.